---
$id: https://graph.org.ai/products/commodity/51111648
$type: Product
source: UNSPSC
code: "51111648"
title: "Oteracil"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oteracil

**UNSPSC Code**: 51111648
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5VT6420TIG. European Medicines Agency schedules Oteracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30899. Oteracil generally arises in the molecular formula C4H3N3O4. The term OTERACIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 no. 3, 1999, list 42.) Most nations schedule oteracil under HS 29336980 and SITC 51576. As of Q4 2014, OTERACIL remains the US FDA Preferred Term for this commodity. Oteracil bears US NLM identifiers UMLS ID C0030032 and NCI Concept Code C76917. SMILES: C1(=NC(=O)NC(=O)N1)C(=O)[O-].[K+].

